97 related articles for article (PubMed ID: 25126810)
1. The impact of possible clonal spread of Acinetobacter baumannii complex bacteremia.
Hsu HY; Chao CM
Crit Care Med; 2014 Sep; 42(9):e628. PubMed ID: 25126810
[No Abstract] [Full Text] [Related]
2. The authors reply.
Lee HY; Chiu CH
Crit Care Med; 2014 Sep; 42(9):e628-9. PubMed ID: 25126811
[No Abstract] [Full Text] [Related]
3. The deadly impact of extreme drug resistance in Acinetobacter baumannii.
Spellberg B; Bonomo RA
Crit Care Med; 2014 May; 42(5):1289-91. PubMed ID: 24736340
[No Abstract] [Full Text] [Related]
4. Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.
Lee HY; Chen CL; Wu SR; Huang CW; Chiu CH
Crit Care Med; 2014 May; 42(5):1081-8. PubMed ID: 24394630
[TBL] [Abstract][Full Text] [Related]
5. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
Lee HY; Huang CW; Chen CL; Wang YH; Chang CJ; Chiu CH
J Microbiol Immunol Infect; 2015 Dec; 48(6):588-96. PubMed ID: 26055692
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Park YK; Jung SI; Park KH; Kim SH; Ko KS
Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
Dizbay M; Tunccan OG; Sezer BE; Hizel K
Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
Lowings M; Ehlers MM; Dreyer AW; Kock MM
BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates.
Lee HY; Hsu SY; Hsu JF; Chen CL; Wang YH; Chiu CH
J Microbiol Immunol Infect; 2018 Jun; 51(3):367-376. PubMed ID: 28830746
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and outcomes of imipenem-resistant Acinetobacter bloodstream infection in North-Eastern Malaysia.
Deris ZZ; Shafei MN; Harun A
Asian Pac J Trop Biomed; 2011 Aug; 1(4):313-5. PubMed ID: 23569782
[TBL] [Abstract][Full Text] [Related]
12. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Jamulitrat S; Arunpan P; Phainuphong P
J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
[TBL] [Abstract][Full Text] [Related]
13. Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study.
Wu W; He Y; Lu J; Lu Y; Wu J; Liu Y
PLoS One; 2015; 10(9):e0137174. PubMed ID: 26340666
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1186-92. PubMed ID: 19860563
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-resistant Acinetobacter baumannii bacteremia in neonates.
Nakwan N; Chokephaibulkit K
Pediatr Infect Dis J; 2013 Feb; 32(2):197. PubMed ID: 23328831
[No Abstract] [Full Text] [Related]
17. bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii.
Merkier AK; Centrón D
Int J Antimicrob Agents; 2006 Aug; 28(2):110-3. PubMed ID: 16844350
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream infections with OXA-23-producing Acinetobacter baumannii isolates in a university-affiliated hospital in Brazil: epidemiology and clinical outcomes.
Furtado GH; Cavalcante AC; Medeiros EA; Gales AC; Oliveira VG; Girardelo R
Am J Infect Control; 2011 Oct; 39(8):706-708. PubMed ID: 21784559
[No Abstract] [Full Text] [Related]
19. Outcomes of Acinetobacter baumannii infection in critically ill burned patients.
Trottier V; Segura PG; Namias N; King D; Pizano LR; Schulman CI
J Burn Care Res; 2007; 28(2):248-54. PubMed ID: 17351441
[TBL] [Abstract][Full Text] [Related]
20. A Multicenter Study in Mexico Finds Acinetobacter baumannii Clinical Isolates Belonging to Clonal Complexes 636B (113B) and 92B Harboring OXA-72, OXA-239, and OXA-469.
Gonzalez-Villoria AM; Tamayo-Legorreta E; Garza-Ramos U; Barrios H; Sanchez-Pérez A; Rodríguez-Medina N; Uribe-Aviña N; Cevallos MA; ; Silva-Sanchez J
Antimicrob Agents Chemother; 2016 Apr; 60(4):2587-8. PubMed ID: 26833167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
